BNTX News and Press, BioNTech SE From 03/06/23

2023-03-06 09:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-06 07:47:59 ET Vir Biotechnology ( NASDAQ: VIR ) added ~5% pre-market Monday after JPMorgan upgraded the COVID-19 drugmaker citing upcoming data readouts for VIR-2482 and VIR-2218, candidates targeted at influenza A and Hepatitis B Virus, respectively. In mid-202...

2023-03-04 13:45:00 ET A record $138B was invested by the 15 largest pharmaceutical companies in 2022, a staggering 43% increase since 2017, according to an IQVIA report. That $138B accounted for ~19% of these companies' overall sales. IQVIA also found that although biopharma in...

Summary Their latest COVID-19 vaccine is up for approvals in pediatric populations. In the first half, the COVID-19/flu shot combo has an early look. At least one of the clinical readouts in oncology are likely to be positive. Biopharmaceutical New Technologies or BioNTech...

Summary Novavax has issued dire warnings to shareholders as the company continues to burn substantial amounts of cash. The small biotech continues to dilute shareholders via near-endless share issuances, and no guarantees exist that the company will have a successful 2023 vaccine update...

BioNTech ( NASDAQ: BNTX ) said it will set up an mRNA Excellence Center to conduct research with scientists at the Weizmann Institute of Science in Israel. The German mRNA COVID vaccine maker signed a Memorandum of Understanding (MoU) with Weizmann under which scientists fro...

JERUSALEM, Israel, March 1, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science (“Weizmann Institute”) signed a Memorandum of Understanding (MoU). As part of this M...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Pharma giant Pfizer (NYSE: PFE) , is the co-developer with Germany's BioNTech (NASDAQ: BNTX) of one of the international vaccines against COVID-19. The pair has seen much success from the COVID-19 vaccine with it contributing the bulk of Pfizer's operational growth of 30% year ove...

Summary The COVID-19 public health emergency is coming to end in May 2023. As a result, Moderna, Inc. is approaching a long earnings trough after a couple years of mind-blowing growth. The market is going to hyper-fixate on the expected year-over-year declines in earnings in the upcomin...